Animal Drugs, Feeds, and Related Products; Xylazine Injection
other · Food and Drug Administration · Rule · Published 1995-07-06 · Effective 1995-07-06 · 60 FR 35122
Document
Document number
95-16625
Federal Register citation
60 FR 35122
CFR reference
21 CFR 510
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
1995-07-06
Effective date
1995-07-06
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Lloyd, Inc. The supplemental NADA provides for intravenous, intramuscular, or subcutaneous use of xylazine injection in cats to produce sedation accompanied by a shorter period of analgesia.